ENGN
Price
$1.82
Change
-$0.01 (-0.55%)
Updated
Sep 4, 04:30 PM (EDT)
Capitalization
122.26M
12 days until earnings call
Intraday BUY SELL Signals
NAGE
Price
$3.12
Change
+$0.01 (+0.32%)
Updated
Sep 4, 01:00 PM (EDT)
Capitalization
246.48M
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ENGN vs NAGE

ENGN vs NAGE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ENGN vs. NAGE commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENGN is a StrongBuy and NAGE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2026
Stock price -- (ENGN: $1.83 vs. NAGE: $3.11)
Brand notoriety: ENGN and NAGE are both not notable
ENGN represents the Biotechnology, while NAGE is part of the Food: Major Diversified industry
Current volume relative to the 65-day Moving Average: ENGN: 91% vs. NAGE: 35%
Market capitalization -- ENGN: $122.26M vs. NAGE: $246.48M
ENGN [@Biotechnology] is valued at $122.26M. NAGE’s [@Food: Major Diversified] market capitalization is $246.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $141.42B to $0. The market cap for tickers in the [@Food: Major Diversified] industry ranges from $255.67B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B. The average market capitalization across the [@Food: Major Diversified] industry is $3.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENGN’s FA Score shows that 1 FA rating(s) are green whileNAGE’s FA Score has 0 green FA rating(s).

  • ENGN’s FA Score: 1 green, 4 red.
  • NAGE’s FA Score: 0 green, 5 red.
According to our system of comparison, both ENGN and NAGE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENGN’s TA Score shows that 5 TA indicator(s) are bullish while NAGE’s TA Score has 3 bullish TA indicator(s).

  • ENGN’s TA Score: 5 bullish, 4 bearish.
  • NAGE’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ENGN is a better buy in the short-term than NAGE.

Price Growth

ENGN (@Biotechnology) experienced а -4.19% price change this week, while NAGE (@Food: Major Diversified) price change was -3.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.43%. For the same industry, the average monthly price growth was +6.98%, and the average quarterly price growth was +2391.73%.

The average weekly price growth across all stocks in the @Food: Major Diversified industry was -3.14%. For the same industry, the average monthly price growth was -3.16%, and the average quarterly price growth was -9.68%.

Reported Earning Dates

ENGN is expected to report earnings on Sep 16, 2026.

NAGE is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Biotechnology (+1.43% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Food: Major Diversified (-3.14% weekly)

Companies in this industry usually make a diverse range of agricultural and/or processed food. Some prominent names in this segment are Mondelez International, which makes chocolates, biscuits, cookies etc. The Kraft Heinz Company specializes in ketchups, sauces, fruit drink pouches and many more. General Mills, Inc. sells flour and cereal. Kellogg is famous for its snacks and breakfast cereal. And so on down the line. As more and more consumers are looking for healthier options in food in recent years, several legacy food companies have responded by revamping brands to include organic and no-added-sugar versions, and/or acquiring healthy food firms, and even streamlining operations.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAGE($246M) has a higher market cap than ENGN($122M). NAGE YTD gains are higher at: -51.101 vs. ENGN (-79.734). NAGE has higher annual earnings (EBITDA): 12.6M vs. ENGN (-123.45M). ENGN has more cash in the bank: 258M vs. NAGE (66.4M). NAGE has less debt than ENGN: NAGE (2.58M) vs ENGN (33.4M). NAGE has higher revenues than ENGN: NAGE (130M) vs ENGN (0).
ENGNNAGEENGN / NAGE
Capitalization122M246M50%
EBITDA-123.45M12.6M-980%
Gain YTD-79.734-51.101156%
P/E RatioN/A16.39-
Revenue0130M-
Total Cash258M66.4M389%
Total Debt33.4M2.58M1,297%
FUNDAMENTALS RATINGS
NAGE: Fundamental Ratings
NAGE
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
36
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
41

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENGNNAGE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 8 days ago
83%
Bearish Trend 22 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ENGN
Daily Signal:
Gain/Loss:
NAGE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFQIX8.420.05
+0.60%
Janus Henderson Global Equity Income I
MNDRX27.99N/A
N/A
MFS New Discovery R2
BRWCX27.62N/A
N/A
MFS Blended Research Growth Eq C
NWAYX14.25N/A
N/A
Nationwide GQG US Quality Eq Eagle
AAIZX21.13N/A
N/A
Alger AI Enablers & Adopters Z